Erythroblast transformation-specific-related gene and friend leukaemia virus integration gene 1 are emerging markers for breast angiosarcoma, demonstrating superior sensitivity and specificity compared to CD31 and CD34.[10,11]. This evidence concerns the gene PECAM1 and breast angiosarcoma.